Ministry of Education
Satya Sesha Sai Kiran Pindiprolu
VIDWAN ID: 128799

Dr Satya Sesha Sai Kiran Pindiprolu

Male Doctor of Philosophy
Assistant Professor
ADITYA INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH
Andhra Pradesh
Expertise: Pharmacology and Pharmacy
ORCID 0000-0002-5400-4491 Scopus 57190249632 Google Scholar EZ8WB9IAAAAJ
View older version My Dashboard
49 Publications
1 Projects
656 Scopus Citations
896 CrossRef
9 Years 4 Months Total Experience
Publications
49 Total
Articles
45
Chapters
4
Activity

No publication activity to display.

Scopus Scopus
656 Citations
18 h-index
CrossRef CrossRef
896 Citations
19 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

CSIR-Senior Research Fellowship
2018
Council of Scientific & Industrial Research, Govt.of India
ICMR-Senior Research Fellowship
2018
Indian Council of Medical Research
Tony B Academic Travel Award
2019
Society for Laboratory Automation and Screening
International Travel Grant
2016
Indian Council of Medical Research
International Travel Grant
2016
CICS-Chennai
Best Research Scholar Award
2019
Associaton of Pharmacy Professionals, India
International Travel Grant
2017
DST-SERB
Tony B. Academic Travel Award
2022
Society for Laboratory Automation and Screening
Teachers Associateship for Research Excellence
2021
DST-SERB

Community & Membership

Aditya Pharmacy College
Co-Ordinator, Research and Development (R&D) Committee
Jan 2021
American Association of Pharmaceutical Scientists
Student member
Jan 2017
European Association of Cancer Research
Early career member
Jan 2022
Society for Laboratory Automation and Screening
Basic
Jan 2021

Personal Details

Doctor of Philosophy
2019
N/A
Master of Arts
2016
Bhoramdev College of Agriculture
Bachelor of Pharmacy
2014
Baba Farid University of Health Sciences, Faridkot
Assistant Professor
Dec 2020 – Present
ADITYA INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH
Assistant Professor
Oct 2019 – May 2020
Jawaharlal Nehru Technological University, Kakinada
Research Fellow
Jul 2016 – May 2019
JSS College of Pharmacy
Medical and Health Sciences
Pharmacology and Pharmacy

Related Profiles

Scholarly Work

octadecylcarbomyl] phenyl boronic acid modified lipid based nanocarriers for inhibition of Notch-1 signalling in triple negative breast cancer cells and cancer stem-like cells
Other
Agency: Department of Science and Technology Role: Principal Investigator Grant: TAR/2021/000054
Amount: ₹18.30 Lac
Duration: 2021 – Ongoing
No Data Found

There is currently nothing to display here.

Solid Lipid Nanocarriers of Surface Modified Niclosamide for targeting of Sialic Acid Receptors

Praveen T. Krishnamurthy
Pavan Kumar Chintamaneni
Pindiprolu S.S. Sai Kiran
- Application No. : 201941031322 Filed : 01-08-2019
Published : 05-02-2021 Published

Surface modified benzyl quinolone carboxylic acid- stearylamine conjugates for management of alzheimer’s disease

JSS Academy of Higher Education & Research
- Patent No. : 388590 Filed : 26-06-2019
Published : 02-08-2019 Published

Scholarly Publications

Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles

Journal Article
Drug Delivery. Year: 2016. Volume: 23 , Issue: 9 , Pages: 3505-3519 .
Authors: Tummala, S.; Kumar, M.N.S.; Pindiprolu, S.K.
DOI 10.1080/10717544.2016.1199606 Crossref Crossref: 64

Development and efficacy evaluation of smart nanocarriers for targeting breast cancers

Journal Article
European Journal of Cancer. Year: 2016.
Authors: Talluri, S.; Pindiprolu, S.; Janarthanam, R.; Kuppusamy, G.

Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease

Journal Article
Medical Hypotheses. Year: 2017. Volume: 101 , Pages: 17-22 .
Authors: Chintamaneni, P.K.; Krishnamurthy, P.T.; Rao, P.V.; Pindiprolu, S.S.S.
DOI 10.1016/j.mehy.2017.01.026 Crossref Crossref: 18 Scopus Scopus: 18

Protective Effects of Hydroxytyrosol from Diabetic Peripheral Neuropathy in Rodents: Implications of Antioxidant and Anti-Inflammatory Effects

Journal Article
Year: 2017.
Authors: Suribabu, Ramisetti; Pindiprolu, Saikiran S. S.; Talluri, Siddhartha V.; Chintamaneni, Pavankumar; Samidala, Nageswararao
Scopus Scopus: 9

Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer:: In vitro studies

Open Access
Journal Article
RSC Advances. Year: 2019. Volume: 9 , Issue: 43 , Pages: 24987-24994 .
Authors: Singh, M.K.; Pindiprolu, S.K.S.S.; Reddy Sanapalli, B.K.; Yele, V.; Ganesh, G.N.K.
DOI 10.1039/c9ra04814f Crossref Crossref: 22 Scopus Scopus: 21

Type-II endometrial cancer: role of adipokines

Journal Article
Archives of Gynecology and Obstetrics. Year: 2019. Volume: 300 , Issue: 2 , Pages: 239-249 .
Authors: Garikapati, K.K.; Ammu, V.V.V.R.K.; Krishnamurthy, P.T.; Chintamaneni, P.K.; Pindiprolu, S.K.S.S.
DOI 10.1007/s00404-019-05181-1 Crossref Crossref: 19 Scopus Scopus: 19

Lipid bioconjugated nanocarriers for potentiating chemotherapeutic efficacy and preventing metastasis in triple negative breast cancer

Journal Article
European Journal of Cancer. Year: 2018. Volume: 92 , Pages: S123 .
Authors: Pindiprolu, S. S. S. K.; Krishnamurthy, P. Thaggikuppe; Chintamaneni, P. K.
DOI 10.1016/S0959-8049(18)30592-6

Pharmacological targets of breast cancer stem cells: a review

Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology. Year: 2018. Volume: 391 , Issue: 5 , Pages: 463-479 .
Authors: Pindiprolu, S.K.S.S.; Krishnamurthy, P.T.; Chintamaneni, P.K.
DOI 10.1007/s00210-018-1479-3 Crossref Crossref: 22 Scopus Scopus: 24
Showing 1 to 8 of 49 publications